Cargando…

The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients

Non-alcoholic fatty liver disease (NAFLD) and serum uric acid (SUA) levels are risk factors for developing cardiovascular disease (CVD). Additionally, previous studies have suggested that high SUA levels increase the risk of having NAFLD. However, no study has investigated the relationship between S...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kiduk, Kang, Kyoonho, Sheol, Hyewon, Shin, Jihae, Sim, Youngseo, Yang, Taehoon, Hwang, Jeongwon, Lee, Ju-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834479/
https://www.ncbi.nlm.nih.gov/pubmed/35162067
http://dx.doi.org/10.3390/ijerph19031042
_version_ 1784649197012647936
author Kim, Kiduk
Kang, Kyoonho
Sheol, Hyewon
Shin, Jihae
Sim, Youngseo
Yang, Taehoon
Hwang, Jeongwon
Lee, Ju-Mi
author_facet Kim, Kiduk
Kang, Kyoonho
Sheol, Hyewon
Shin, Jihae
Sim, Youngseo
Yang, Taehoon
Hwang, Jeongwon
Lee, Ju-Mi
author_sort Kim, Kiduk
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) and serum uric acid (SUA) levels are risk factors for developing cardiovascular disease (CVD). Additionally, previous studies have suggested that high SUA levels increase the risk of having NAFLD. However, no study has investigated the relationship between SUA and CVD risk in NAFLD. This study analyzed the relationship between SUA and CVD in NAFLD. Data for this study used the 2016–2018 Korean National Health and Nutrition Examination Survey, which represents the Korean population. A total of 11,160 NAFLD patients were included. Participants with hepatic steatosis index ≥ 30 were considered to have NAFLD. Ten-year CVD risk was estimated using an integer-based Framingham risk score. Estimated 10-year CVD risk ≥ 20% was considered high risk. Multiple logistic regression was conducted to calculate the odds ratios (ORs) associated with SUA level and CVD risk. High CVD risk OR increases by 1.31 (95% CI 1.26–1.37) times per 1 mg/dL of SUA. After adjustment, SUA still had an increased risk (OR 1.44; 95% CI 1.38–1.51) of CVD. Compared with the lowest SUA quartile group, the highest quartile group showed a significantly higher risk of having CVD before (OR 2.76; 95% CI 2.34–3.25) and after (OR 4.01; 95% CI 3.37–4.78) adjustment. SUA is independently associated with CVS risk in NAFLD.
format Online
Article
Text
id pubmed-8834479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88344792022-02-12 The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients Kim, Kiduk Kang, Kyoonho Sheol, Hyewon Shin, Jihae Sim, Youngseo Yang, Taehoon Hwang, Jeongwon Lee, Ju-Mi Int J Environ Res Public Health Article Non-alcoholic fatty liver disease (NAFLD) and serum uric acid (SUA) levels are risk factors for developing cardiovascular disease (CVD). Additionally, previous studies have suggested that high SUA levels increase the risk of having NAFLD. However, no study has investigated the relationship between SUA and CVD risk in NAFLD. This study analyzed the relationship between SUA and CVD in NAFLD. Data for this study used the 2016–2018 Korean National Health and Nutrition Examination Survey, which represents the Korean population. A total of 11,160 NAFLD patients were included. Participants with hepatic steatosis index ≥ 30 were considered to have NAFLD. Ten-year CVD risk was estimated using an integer-based Framingham risk score. Estimated 10-year CVD risk ≥ 20% was considered high risk. Multiple logistic regression was conducted to calculate the odds ratios (ORs) associated with SUA level and CVD risk. High CVD risk OR increases by 1.31 (95% CI 1.26–1.37) times per 1 mg/dL of SUA. After adjustment, SUA still had an increased risk (OR 1.44; 95% CI 1.38–1.51) of CVD. Compared with the lowest SUA quartile group, the highest quartile group showed a significantly higher risk of having CVD before (OR 2.76; 95% CI 2.34–3.25) and after (OR 4.01; 95% CI 3.37–4.78) adjustment. SUA is independently associated with CVS risk in NAFLD. MDPI 2022-01-18 /pmc/articles/PMC8834479/ /pubmed/35162067 http://dx.doi.org/10.3390/ijerph19031042 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Kiduk
Kang, Kyoonho
Sheol, Hyewon
Shin, Jihae
Sim, Youngseo
Yang, Taehoon
Hwang, Jeongwon
Lee, Ju-Mi
The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients
title The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients
title_full The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients
title_fullStr The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients
title_full_unstemmed The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients
title_short The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients
title_sort association between serum uric acid levels and 10-year cardiovascular disease risk in non-alcoholic fatty liver disease patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834479/
https://www.ncbi.nlm.nih.gov/pubmed/35162067
http://dx.doi.org/10.3390/ijerph19031042
work_keys_str_mv AT kimkiduk theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT kangkyoonho theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT sheolhyewon theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT shinjihae theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT simyoungseo theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT yangtaehoon theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT hwangjeongwon theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT leejumi theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT kimkiduk associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT kangkyoonho associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT sheolhyewon associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT shinjihae associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT simyoungseo associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT yangtaehoon associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT hwangjeongwon associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients
AT leejumi associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients